Healthcare -
Biotechnology - NASDAQ - US
$ 41.1
1.61 %
$ 2.66 B
Market Cap
-17.56
P/E
KYMR - CASH & EQUIVALENTS
Cash & Equivalents KYMR - Kymera Therapeutics, Inc.
110 M
LAST VALUE
51.40%
2 YEAR CAGR
21.66%
5 YEAR CAGR
0.00%
10 YEAR CAGR